Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

ONTOLOGY REPORT - ANNOTATIONS


Term:1-(4-methoxyphenyl)methanamine
go back to main search page
Accession:CHEBI:49837 term browser browse the term
Definition:An aralkylamino compound that is benzylamine substituted by a methoxy group at the para position.
Synonyms:related_synonym: 4-Methoxybenzylamine;   Formula=C8H11NO;   InChI=1S/C8H11NO/c1-10-8-4-2-7(6-9)3-5-8/h2-5H,6,9H2,1H3;   InChIKey=IDPURXSQCKYKIJ-UHFFFAOYSA-N;   SMILES=COc1ccc(CN)cc1;   p-Anisylamine
 xref: CAS:2393-23-9 "ChemIDplus";   PDBeChem:PZM;   PMID:1394653 "Europe PMC";   PMID:16292851 "Europe PMC";   PMID:21617772 "Europe PMC";   Reaxys:508206 "Reaxys"


show annotations for term's descendants       view all columns           Sort by:
 

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 0
    role 0
      application 0
        refrigerant 0
          ammonia 0
            organic amino compound 0
              primary amino compound 0
                1-(4-methoxyphenyl)methanamine 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 0
    subatomic particle 0
      composite particle 0
        hadron 0
          baryon 0
            nucleon 0
              atomic nucleus 0
                atom 0
                  main group element atom 0
                    main group molecular entity 0
                      s-block molecular entity 0
                        hydrogen molecular entity 0
                          hydrides 0
                            inorganic hydride 0
                              pnictogen hydride 0
                                nitrogen hydride 0
                                  azane 0
                                    ammonia 0
                                      organic amino compound 0
                                        aralkylamino compound 0
                                          1-(4-methoxyphenyl)methanamine 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.